Results 201 to 210 of about 181,689 (337)
A newly proposed endoscopic score system to evaluate the entire small bowel and predict the prognosis in Crohn’s disease [PDF]
Small bowel stenosis in patients with Crohn’s disease leads to abdominal symptoms and can affect prognosis. The Simple Endoscopic Score for Crohn’s Disease for the large bowel has been applied to the small bowel; however, stenosis scoring may be ...
Furukawa, Kazuhiro+16 more
core
Expression of the T-Cell Chemoattractant Chemokine Lymphotactin in Crohn’s Disease [PDF]
Peter Middel+9 more
openalex +1 more source
ABSTRACT We report on a 31‐year‐old male patient diagnosed with active moderate‐to‐severe ulcerative colitis and a history of splenectomy. He was hospitalized due to confluent pustular oral lesions and multiple skin abscesses. After ruling out an infection, we diagnosed pyostomatitis vegetans associated with aseptic abscess syndrome.
C. Dandoy+6 more
wiley +1 more source
ABSTRACT Background Cutaneous Crohn's disease (CCD) is a granulomatous condition of the skin discontiguous from the gastrointestinal tract. Cutaneous disease rarely correlates with intestinal disease and often requires separate treatment. While the use of interleukin‐12/23 (IL‐12/IL‐23) and interleukin‐23 (IL‐23) inhibitors is FDA‐approved for ...
G. E. McKay+14 more
wiley +1 more source
Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn’s disease [PDF]
Richard Goodgame+6 more
openalex +1 more source
Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn’s disease [PDF]
P. Lundin+3 more
openalex +1 more source
Exploring the Cutaneous Associations of Crohn's Disease: A Retrospective Study of 108 Patients
ABSTRACT Background The integumentary system provides a window into the overall health of individuals and may display cutaneous manifestations of systemic disease. Crohn's Disease (CD) is a relapsing inflammatory bowel disease that exhibits a significant symptomatic burden on a global scale.
Max E. Oscherwitz+4 more
wiley +1 more source
Infliximab induces potent anti‐inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease [PDF]
Freddy Cornillie+10 more
openalex +1 more source